Goldman Sachs
INVA icon

Goldman Sachs’s Innoviva INVA Stock Holding History

Goldman Sachs’s Portfolio INVA Stock Details INVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-650,000
Closed -$6.96M – 6880
2016
Q4 		$6.96M Sell
650,000
-3,957,400
-86% -$41.5M ﹤0.01% 2767
2016
Q3 		$50.6M Buy
4,607,400
+2,723,500
+145% +$31.8M 0.02% 1198
2016
Q2 		$19.8M Buy
+1,883,900
New +$22.3M 0.01% 1792
2015
Q4 		– Sell
-53,000
Closed -$381K – 7241
2015
Q3 		$381K Buy
+53,000
New +$720K ﹤0.01% 5402
2015
Q2 		– Sell
-228,200
Closed -$3.59M – 7338
2015
Q1 		$3.59M Buy
228,200
+28,200
+14% +$427K ﹤0.01% 3217
2014
Q4 		$2.83M Buy
+200,000
New +$3.01M ﹤0.01% 3510
2014
Q2 		– Sell
-37,230
Closed -$928K – 7069
2014
Q1 		$928K Sell
37,230
-260,858
-88% -$7.64M ﹤0.01% 4747
2013
Q4 		$8.56M Buy
+298,088
New +$8.72M ﹤0.01% 2504

Other funds holding INVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $5.02B AUM 66.06% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Goldman Sachs's INVA Position: Q2 2026 in Review

Goldman Sachs increased its Innoviva (INVA) stake by 1.7% in Q2 2026, buying an estimated $611K and bringing the position to 1,620,093 shares worth $36.8M. The position accounts for ﹤0.01% of the portfolio, ranked #2073.

Goldman Sachs first reported a position in INVA in Q2 2013 and has held it in 53 quarters since. The position peaked at $37.1M in Q1 2026. 309 funds tracked by Wall St. Rank hold INVA as of Q2 2026.

  • Goldman Sachs held 1,620,093 shares of Innoviva worth $36.8M as of Q2 2026.
  • Goldman Sachs bought 26,710 Innoviva shares in Q2 2026, an estimated $611K.
  • Innoviva made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #2073 holding.
  • Goldman Sachs first reported a position in Innoviva in Q2 2013 and has held it in 53 quarters since.
  • Goldman Sachs's Innoviva position peaked at $37.1M in Q1 2026.
  • 309 funds tracked by Wall St. Rank held Innoviva as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.